Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Diatron Presents High-Quality Hematology and Clinical Chemistry Products

By LabMedica International staff writers
Posted on 29 Jul 2025

Diatron (Budapest, Hungary) is exhibiting at ADLM 2025, where the company is presenting its newly launched clinical chemistry analyzer alongside other high-quality hematology products. More...

Diatron’s new clinical chemistry analyzer, the P780, which is being introduced at the show, is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories. Ideal for a variety of lab sizes, from medium to large, the P780 is engineered for high reliability, offering an innovative and scalable solution. As Diatron’s flagship clinical chemistry analyzer, the P780 excels in maximum throughput, which is enabled by uninterrupted photometric tests and an independent ISE arm. As a result, the P780 allows continuous operation under demanding workloads, ensuring fast turnaround times without compromising accuracy. The system is equipped with a dual concentric reagent tray with cooled positions for calibrators and controls, plus an optional Auto Filling Draining Module that enables nonstop operation and reduces manual work.

A built-in panel PC with a touchscreen interface helps to minimize the instrument’s footprint and streamline daily use. The system features advanced software, delivering an intuitive, easy-to-use interface and a comprehensive dashboard, with real-time worklist monitoring and flexible workflow management tools to simplify daily lab procedures. Diatron is also showcasing Aquila, its innovative and revolutionary 3-part differential hematology analyzer that can be used in any testing location and application where high-quality CBC results are desired. The company’s latest technology offers the optimal testing solution for both the experienced and inexperienced user, and practices that require a high-quality hematology analyzer.

Diatron is also highlighting its Aquarius 3 hematology analyzer that combines technology and simplicity to give all the required information, reducing the unnecessary steps to a minimum whilst maintaining the balance between cost and benefit for patients and users alike. With a sleek, new modern design, the Aquarius 3 interface offers a positive touch and feeling, with all actions designed to increase efficiency, saving time to perform other important tasks. The new Aquarius 3 software features a high level of patient management and workflow optimization to avoid repetition whilst only having a small reagent consumption.

Related Links:
Diatron


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.